MedReleaf (TSE: LEAF) Announces 3rd Quarter Financials

MedReleaf posted the company’s third quarter financials this morning. The numbers speak for themselves.

  • Sold 1,263 kilograms of cannabis products an increase of 27% from the prior year period
  • Total sales of $11.4 million, an increase of 9% from the prior year period
  • At the end of December 31, 2017, the Company had cash and cash equivalents of $114.6 million, working capital of $137.9 million.

Third Quarter Fiscal 2018 Financial Summary

Three Months

December 31,

CAD$ (in 000s, except grams sold)

2017

2016

Dried Cannabis

8,573

9,831

Extracts

2,349

296

Other

428

299

Total Sales

11,350

10,426

Gross Profit

9,985

9,714

Adjusted Product Contribution Margin*

7,330

8,594

Adjusted EBITDA*

(233)

4,093

Net Income (loss)

(5,001)

1,738

Net Income (loss) per share – diluted

$(0.05)

$0.02

Total grams sold*

1,263,490

993,259

Average selling price per gram – Dried Cannabis

$8.05

$10.41

Average selling price per gram – Extracts

$11.83

$6.11

Total average selling price per gram

$8.98

$10.50

Adjusted product contribution per gram sold*

$5.80

$8.65

Cash cost per gram sold*

$1.83

$1.55

*Non-IFRS Measures

Link to the press release

Related posts

Liberty Health Sciences Opens Its 16th Florida Dispensary In The State’s Capital, Tallahassee

CCT IMPACT Agent

The Green Organic Dutchman Enters Danish Cannabis Market with Joint Venture

Editor

MJIC Announces New Northern California Distribution, Manufacturing and Delivery Facility

creativemind

Leave a Comment